Literature DB >> 23125964

Protocol deviation and violation.

Arun Bhatt1.   

Abstract

Entities:  

Year:  2012        PMID: 23125964      PMCID: PMC3487227          DOI: 10.4103/2229-3485.100663

Source DB:  PubMed          Journal:  Perspect Clin Res        ISSN: 2229-3485


× No keyword cloud information.

WHAT IS THE DIFFERENCE BETWEEN PROTOCOL DEVIATION AND PROTOCOL VIOLATION?

Some suggested definitions are as follows:

Food and drug administration

Compliance Program Guidance Manual

Bioresearch monitoring clinical investigators

A protocol deviation/violation is generally an unplanned excursion from the protocol that is not implemented or intended as a systematic change Protocol deviation is also used to refer to any other, unplanned, instance(s) of protocol noncompliance

EFGCP Audit Working Party 2001

Protocol violation: Serious non-compliance – may lead to exclusion of patients from eligibility analysis and/or their discontinuation from the study Protocol deviation: Less serious non-compliance – may not render a patient ineligible

Norman M. Goldfarb Journal of Clinical Research Best Practices Nov 2005

Protocol deviation. A protocol deviation occurs when, without significant consequences, the activities on a study diverge from the Institutional Review Board-approved protocol, e.g., missing a visit window because the subject is traveling. Not as serious as a protocol violation. Protocol violation. A divergence from the protocol that materially (a) reduces the quality or completeness of the data, (b) makes the Informed Consent Form inaccurate, or (c) impacts a subject's safety, rights, or welfare. Examples of protocol violations may include the following: Inadequate or delinquent informed consent Inclusion/exclusion criteria not met Unreported serious adverse events Improper breaking of the blind Use of prohibited medication Incorrect or missing tests Mishandled samples Multiple visits missed or outside permissible windows Materially inadequate record keeping Intentional deviation from protocol, Good Clinical Practice, or regulations by study personnel Subject repeated non-compliance with study requirements
  8 in total

1.  Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experience.

Authors:  Shinsuke Sasada; Nobuko Ushirozawa; Noriko Kobayashi; Yutaka Fujiwara; Kenji Tamura; Noboru Yamamoto
Journal:  Invest New Drugs       Date:  2017-02-01       Impact factor: 3.850

Review 2.  Text Classification for Clinical Trial Operations: Evaluation and Comparison of Natural Language Processing Techniques.

Authors:  Emma Richard; Bhargava Reddy
Journal:  Ther Innov Regul Sci       Date:  2020-10-30       Impact factor: 1.778

3.  Long-chain omega-3 fatty acids in aneurysmal subarachnoid hemorrhage: A randomized pilot trial of pharmaconutrition.

Authors:  Geisi Saito; Rodrigo Zapata; Rodrigo Rivera; Héctor Zambrano; David Rojas; Hernán Acevedo; Franco Ravera; John Mosquera; Juan E Vásquez; Jorge Mura
Journal:  Surg Neurol Int       Date:  2017-12-27

4.  Protocol adherence for continuously titrated interventions in randomized trials: an overview of the current methodology and case study.

Authors:  F Lauzier; N K Adhikari; A Seely; K K Y Koo; E P Belley-Côté; K E A Burns; D J Cook; F D'Aragon; B Rochwerg; M E Kho; S J W Oczkowksi; E H Duan; M O Meade; A G Day; F Lamontagne
Journal:  BMC Med Res Methodol       Date:  2017-07-17       Impact factor: 4.615

5.  Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT.

Authors:  Jennie Johnstone; Diane Heels-Ansdell; Lehana Thabane; Maureen Meade; John Marshall; Francois Lauzier; Erick Huaileigh Duan; Nicole Zytaruk; Daphnee Lamarche; Michael Surette; Deborah J Cook
Journal:  BMJ Open       Date:  2019-06-20       Impact factor: 2.692

6.  Practical challenges and Obligations for conducting Clinical Trial in Nepal: A call for improvement.

Authors:  Muhamed Ibnas; Mohammad Asim; Ahammed Mekkodathil; Brijesh Sathian
Journal:  Nepal J Epidemiol       Date:  2019-09-30

7.  Assessment and classification of protocol deviations.

Authors:  Ravindra Bhaskar Ghooi; Neelambari Bhosale; Reena Wadhwani; Pathik Divate; Uma Divate
Journal:  Perspect Clin Res       Date:  2016 Jul-Sep

8.  Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Mahsa Miryan; Pezhman Alavinejad; Mohammadreza Abbaspour; Davood Soleimani; Alireza Ostadrahimi
Journal:  Trials       Date:  2020-08-05       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.